![Alexander Cross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexander Cross
No open positions remaining
Profile
Alexander D.
Cross served as President & CEO of Zoecon Corp.
from 1979 to 1985.
He was also Chairman & CEO of CytoPharm, Inc. Additionally, he served as a Director at MDRNA, Inc. and Ligand Pharmaceuticals, Inc. and as an Independent Director at Atossa Therapeutics, Inc. He was a Principal at NDA Partners LLC from 2003 to 2018.
Dr. Cross received his undergraduate and doctorate degrees from The University of Nottingham.
Former positions of Alexander Cross
| Companies | Position | End |
|---|---|---|
NDA Partners LLC
 NDA Partners LLC Miscellaneous Commercial ServicesCommercial Services Provides strategy consulting services | Corporate Officer/Principal | 11/06/2018 |
| ATOSSA THERAPEUTICS, INC. | Director/Board Member | 31/12/2013 |
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services Researches, develops, manufactures and commercializes nasally administered forms of pharmaceuticals | Director/Board Member | 20/05/2009 |
| LIGAND PHARMACEUTICALS INCORPORATED | Director/Board Member | 17/03/2007 |
CytoPharm, Inc.
 CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology Develops natural interferon products | Chairman | 01/08/2006 |
Training of Alexander Cross
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
32
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services Researches, develops, manufactures and commercializes nasally administered forms of pharmaceuticals | Commercial Services |
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Atossa Therapeutics, Inc.
 Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NDA Partners LLC
NDA Partners LLC Miscellaneous Commercial ServicesCommercial Services Provides strategy consulting services | Commercial Services |
Zoecon Corp. | |
CytoPharm, Inc.
CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology Develops natural interferon products | Health Technology |
- Stock Market
- Insiders
- Alexander Cross
